Standardizing the inclusion of indirect medical costs in economic evaluations

PharmacoEconomics

Volumn 29, Issue 3, 2011, Pages 175-187

  Van Baal, Pieter H M ^a,b   Wong, Albert ^a,c   Slobbe, Laurentius C J ^a   Polder, Johan J ^a,c   Brouwer, Werner B F ^b   De Wit, G Ardine ^a,d  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c TILBURG UNIVERSITY   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; COMPUTER MODEL; COMPUTER PROGRAM; ECONOMIC EVALUATION; HEALTH CARE COST; NETHERLANDS; PRIORITY JOURNAL; SEX; STANDARD; TIME OF DEATH;

HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS;

EID: 79951654415     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/11586130-000000000-00000     Document Type: Article

References (31)

1. Garber AM, Phelps CE. Economic foundations of costeffectiveness analysis. J Health Econ 1997 Feb; 16 (1): 1-31
2. Meltzer D, Egleston B, Stoffel D, et al. Effect of future costs on cost-effectiveness of medical interventions among young adults: the example of intensive therapy for type 1 diabetes mellitus. Med Care 2000 Jun; 38 (6): 679-85
3. Nyman JA. Should the consumption of survivors be included as a cost in cost-utility analysis? Health Econ 2004 May; 13 (5): 417-27 (Pubitemid 38660391)
4. Wong A., van Baal P.H.M., Boshuizen H.C., Polder J.J. Exploring the influence of proximity to death on disease-specific hospital expenditures: A carpaccio of red herrings. Health Economics(2011), 20(4), page:379-400, DOI: 10.1002/hec.1597
5. Lee RH. Future costs in cost effectiveness analysis. J Health Econ 2008 Jul; 27 (4): 809-18
6. Meltzer D. Response to 'Future costs and the future of cost-effectiveness analysis'. J Health Econ 2008 Jul; 27 (4): 822-5
7. Feenstra TL, van Baal PH, Gandjour A, et al. Future costs in economic evaluation: a comment on Lee. J Health Econ 2008 Dec; 27 (6): 1645-9; discussion 1650-1
8. Rappange DR, van Baal PH, van Exel NJ, et al. Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions? Pharmacoeconomics 2008; 26 (10): 815-30
9. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: NICE, 2008 Jun
10. Rapport Richtlijnen voor farmaco-economisch onderzoek; evaluatie en actualisatie. Diemen: College voor Zorgverzekeringen, 2006
11. van Baal PHM, Feenstra TL, Polder JJ, et al. Economic evaluation and the postponement of health care costs. Health Econ. Epub 2010 Apr 5
12. Manns B, Meltzer D, Taub K, et al. Illustrating the impact of including future costs in economic evaluations: an application to end-stage renal disease care. Health Econ 2003 Nov; 12 (11): 949-58 (Pubitemid 37407339)
13. de Kok I, Polder J, Habbema J, et al. The impact of healthcare costs in the last year of life and in all life years gained on the cost-effectiveness of cancer screening. Br J Cancer 2009; 100 (8): 1240-4
14. van den Berg M, van Baal PH, Tariq L, et al. The costeffectiveness of increasing alcohol taxes: a modelling study. BMC Med 2008 Nov 28; 6: 36
15. van Baal PH, van den Berg M, Hoogenveen RT, et al. Costeffectiveness of a low-calorie diet and orlistat for obese persons: modeling long-term health gains through prevention of obesity-related chronic diseases. Value Health 2008 Dec; 11 (7): 1033-40
16. Zweifel P, Felder S, Meiers M. Ageing of population and health care expenditure: a red herring? Health Econ 1999 Sep; 8 (6): 485-96 (Pubitemid 29462240)
17. Polder JJ, Barendregt JJ, van Oers H. Health care costs in the last year of life: the Dutch experience. Soc Sci Med 2006 Oct; 63 (7): 1720-31 (Pubitemid 44176177)
18. SeshamaniM, Gray A. Ageing and health-care expenditure: the red herring argument revisited. Health Econ 2004 Apr; 13 (4): 303-14 (Pubitemid 38477075)
19. Hakkinen U, Martikainen P, Noro A, et al. Aging, health expenditure, proximity to death, and income in Finland. Health Econ Policy Law 2008 Apr; 3 (Pt 2): 165-95 (Pubitemid 351493996)
20. O'Neill C, Groom L, Avery AJ, et al. Age and proximity to death as predictors of GP care costs: results from a study of nursing home patients. Health Econ 2000 Dec; 9 (8): 733-8 (Pubitemid 32046778)
21. Werblow A, Felder S, Zweifel P. Population ageing and health care expenditure: a school of 'red herrings'? Health Econ 2007 Oct; 16 (10): 1109-26 (Pubitemid 47534736)
22. Wong A, van Baal PH, Boshuizen HC, et al. Exploring the influence of proximity to death on disease-specific hospital expenditures: a carpaccio of red herrings. Health Econ. Epub 2010 Mar 15
23. Gandjour A, Lauterbach KW. Does prevention save costs? Considering deferral of the expensive last year of life. J Health Econ 2005 Jul; 24 (4): 715-24 (Pubitemid 40800155)
24. Poos M, Smit J, Groen J, et al. Kosten van ziekten in Nederland 2005. Bilthoven: RIVM, 2008. RIVM rapport no. 270751019
25. Polder JJ, Meerding WJ, Koopmanschap MA, et al. The cost of sickness in the Netherlands in 1994: the main determinants were advanced age and disabling conditions. Ned Tijdschr Geneeskd 1998 Jul 11; 142 (28): 1607-11 (Pubitemid 28330975)
26. Meerding WJ, Bonneux L, Polder JJ, et al. Demographic and epidemiological determinants of healthcare costs in Netherlands: cost of illness study. BMJ 1998 Jul 11; 317 (7151): 111-5 (Pubitemid 28310617)
27. Slobbe L, Kommer G, Smit J, et al. Kosten van ziekten in Nederland 2003. Zorg voor euro's-1. Bilthoven: RIVM, 2006
28. Orosz E, Morgan D. SHA-based national health accounts in thirteen OECD countries: a comparative analysis. OECD health working papers no. 16. Paris: OECD, 2004 [online]. Available from URL: http://www.oecd.org/dataoecd/10/53/ 33661480.pdf [Accessed 2010 Jan 1]
29. Voorburg/Heerlen, Netherlands Central Bureau of Statistics 1999 [online]. Available from URL: [Accessed 2010 Jan 1]
30. Heijink R, Noethen M, Renaud T, et al. Cost of illness: an international comparison. Australia, Canada, France, Germany and the Netherlands. Health Policy 2008 Oct; 88 (1): 49-61
31. Payne G, Laporte A, Deber R, et al. Counting backward to health care's future: using time-to-death modeling to identify changes in end-of-life morbidity and the impact of aging on health care expenditures. Milbank Q 2007; 85 (2): 213-57